摘要
目的评价联合肝脏切除治疗肝门部胆管癌的临床效果。方法回顾性分析21例肝门部胆管癌联合肝脏切除的临床资料。结果联合行右半肝切除术者5例，左半肝切除者12例，其他方式4例。术后并发症发生率27．5％，无围手术期死亡，随访1、3、5年的生存率为67．5％、27．6％、18．4％。结论肝门部胆管癌联合肝脏切除可以提高术后生存率，改善预后。
Objective To evaluate the effect of surgical treatment of hilar cholangiocarcinoma with combined hepatic resection. Methods The clinical data of 21 cases with cholangiocarcinoma were analyzed retrospectively. Results All of 5 cases were performed with right hemihepatectomy, 12 cases undergoing with left hemihepatectomy and 4 cases with other methods of precedures.There were no patients died during perioperation, while the incidence of surgical compications was 27.5%.The 1, 3, 5years of survival rate were 67.5%,27.6% and 18.4% respectively. Conclusion The redical approach with combined hepatic resection is effective to improve survival rates in patients with hilar cholangiocarcinoma.
出处
《国际医药卫生导报》
2008年第16期54-56,共3页
International Medicine and Health Guidance News
关键词
肝门部胆管癌
肝切除
预后
Hilar cholangiocarcinoma Hepatic resection Prognosis
